3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Classical hematology
1
Conditions
Venous Thromboembolism
1
Pulmonary Embolism
1
Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
1
Multiple Myeloma
1
Lymphoma
1
Leukemia
1
Hematologic Neoplasms
1
Interventions
Cyclophosphamide
50
fludarabine phosphate
47
Busulfan
46
Cyclosporine
36
Antilymphocyte Serum
33
Cytarabine
32
Peripheral Blood Stem Cell Transplantation
30
Radiotherapy
28
Filgrastim
27
Methotrexate
23
Melphalan
23
Mycophenolic Acid
21
Cord Blood Stem Cell Transplantation
21
Methylprednisolone
20
Etoposide
17
Whole-Body Irradiation
16
Tacrolimus
15
Daunorubicin
11
Epoetin Alfa
10
fludarabine
9
Thiotepa
9
Alemtuzumab
8
Idarubicin
7
Granulocyte Colony-Stimulating Factor
7
sargramostim
6
Topotecan
6
Mitoxantrone
6
Azacitidine
6
Arsenic Trioxide
6
Gemtuzumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia
×
enoxaparin sodium
×
Classical hematology
×
Clear all
NCT07270263
2025-12-26
HEM-DOAC
Medical University of Gdansk
Phase NA
Recruiting
100 enrolled